found tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain Tirzepatide can effectively treat T2D

The SURPASS-1 trial demonstrated significant improvements in glycemic control and substantial reductions in body weight with all three doses of tirzepatide (5 mg, 10 mg, or 15 mg) compared to placebo over a 40-week period

When food and waste sit in the small intestine for longer than they should, it creates an environment where bacteria can can overgrow

That said, some people do successfully transition off Ozempic while maintaining some benefits

Her unique approach to wellness allows her to get to the root cause of patient discomfort

The Phase 2 trial published in the New England Journal of Medicine in 2023 showed that participants on the highest dose (12 mg) started showing measurable weight loss by week four